J Clin Aesthet Dermatol. 2024;17(1–2 Suppl 1):S15–S30. Acne Early and sustained reductions in moderate-to-severe acne with fixed-dose clindamycin phosphate 1.2%, benzoyl peroxide 3.1%, and adapalene 0.15% gel Presenters: Julie C.
J Clin Aesthet Dermatol. 2022;15(6 Suppl 1):S19–S25,31 by Amylee Martin, BS; Akshitha Thatiparthi, BS; Jeffrey Liu, BS; and Jashin J. Wu, MD FUNDING: No funding was provided for the preparation
J Clin Aesthet Dermatol. 2021;14(4):14–22. by George Monks, MD; Ryan Rivera-Oyola, MS; Mark Lebwohl, MD Dr. Monks is with the Department of Dermatology, University of Oklahoma College of Medicine in
Innovations in Psoriasis Management Based on Selected Presentations from Music City SCALE Symposium for Cosmetic Advances & Laser Education May 9–11, 2019, Nashville, Tennessee by Jo Ann LeQuang Owner, LeQ Medical, Angleton,
Updates in Psoriasis Management 2019 Based on Selected Presentations from Maui Derm 2019 January 26–30, 2019, Maui, Hawaii by Jo Ann LeQuang Ms. Lequang is Owner of LeQ Medical in Angleton,
Dr. Goldenberg is a consultant and speaker for Abbvie, Celgene, Eli Lilly & Co., Novartis, and SUN and a consultant for Amgen and UCB.
A Message from the Guest Editor and MauiDerm Program Director Dear Colleagues: The 2018 edition of the MauiDerm for Dermatologists meeting had a wide variety of clinical and scientific data